Drugs of abuse radioimmunoassay directory.
This clinical brief is a survey of procedures, components and kits presently available for detecting and quantitating drugs of abuse in biologic fluids by radioimmunoassay (RIA).
D000661:Amphetamine / Q000032:analysis; D001285:Atropine / Q000032:analysis; D001463:Barbiturates / Q000032:analysis; D002188:Cannabis / Q000032:analysis; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000032:analysis; D008635:Mescaline / Q000032:analysis; D009020:Morphine / Q000032:analysis; D009538:Nicotine / Q000032:analysis; D010423:Pentazocine / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000032:analysis*; D010634:Phenobarbital / Q000032:analysis; D010672:Phenytoin / Q000032:analysis; D011863:Radioimmunoassay; D019966:Substance-Related Disorders / Q000175:diagnosis*
D001463:Barbiturates; D004364:Pharmaceutical Preparations; D010672:Phenytoin; D009538:Nicotine; D009020:Morphine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D008635:Mescaline; D010423:Pentazocine; D010634:Phenobarbital